Katharine A. Collier

A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA

Anna-Lisa Doebley, Minjeong Ko, Hanna Liao et al. · Nature Communications · 2022 · 127 citations · Full text

Medicine, Molecular Biology, Oncology +17

Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma

Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah et al. · JAMA Oncology · 2021 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Otto Metzger, Daniel G. Stover, Sarah Asad et al. · JAMA Oncology · 2021 · 75 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma

Lingbin Meng, Katharine A. Collier, Peng Wang et al. · Cells · 2023 · 65 citations · Full text

Life Sciences, Immunology, Oncology +17

Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in <i>BRCA2</i>-Associated Prostate Cancer Resulting From Biallelic <i>BRCA2</i> Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations

Benedito A. Carneiro, Katharine A. Collier, Rebecca J. Nagy et al. · JCO Precision Oncology · 2018 · 63 citations

Medicine, Molecular Biology, Oncology +17